RIPK1 and metabolic dysfunction-associated steatotic liver disease: We further investigated the role of SENP1-mediated RIPK1 suppression in the pathogenesis of NAFLD by feeding mice with HFD for 16 weeks to induce moderate hepatic steatosis, hepatic inflammation, liver damage, and fibrosis18.